vegzelma

Generic: bevacizumab-adcd

Labeler: celltrion usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name vegzelma
Generic Name bevacizumab-adcd
Labeler celltrion usa, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

bevacizumab 100 mg/4mL

Manufacturer
CELLTRION USA, Inc.

Identifiers & Regulatory

Product NDC 72606-011
Product ID 72606-011_46db7808-58a2-4ec9-aa54-17c2602da528
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761268
Listing Expiration 2026-12-31
Marketing Start 2023-04-03

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor-directed antibody interactions [moa] vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72606011
Hyphenated Format 72606-011

Supplemental Identifiers

RxCUI
2627650 2627656 2627658 2627659
UNII
2S9ZZM9Q9V
NUI
N0000193543 N0000178291 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vegzelma (source: ndc)
Generic Name bevacizumab-adcd (source: ndc)
Application Number BLA761268 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/4mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (72606-011-01) / 4 mL in 1 VIAL, SINGLE-USE
  • 10 VIAL, SINGLE-USE in 1 CARTON (72606-011-10) / 4 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (2)

72606-011-01 1 VIAL, SINGLE-USE in 1 CARTON (72606-011-01) / 4 mL in 1 VIAL, SINGLE-USE 72606-011-10 10 VIAL, SINGLE-USE in 1 CARTON (72606-011-10) / 4 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

bevacizumab (100 mg/4mL)

Linked Drug Pages (1)

Vegzelma ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "46db7808-58a2-4ec9-aa54-17c2602da528", "openfda": {"nui": ["N0000193543", "N0000178291", "N0000193542"], "unii": ["2S9ZZM9Q9V"], "rxcui": ["2627650", "2627656", "2627658", "2627659"], "spl_set_id": ["4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["CELLTRION USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (72606-011-01)  / 4 mL in 1 VIAL, SINGLE-USE", "package_ndc": "72606-011-01", "marketing_start_date": "20230403"}, {"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (72606-011-10)  / 4 mL in 1 VIAL, SINGLE-USE", "package_ndc": "72606-011-10", "marketing_start_date": "20230403"}], "brand_name": "Vegzelma", "product_id": "72606-011_46db7808-58a2-4ec9-aa54-17c2602da528", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "72606-011", "generic_name": "bevacizumab-adcd", "labeler_name": "CELLTRION USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vegzelma", "active_ingredients": [{"name": "BEVACIZUMAB", "strength": "100 mg/4mL"}], "application_number": "BLA761268", "marketing_category": "BLA", "marketing_start_date": "20230403", "listing_expiration_date": "20261231"}